Cogentix Medical, Inc. (NASDAQ:CGNT) is scheduled to be releasing its earnings data after the market closes on Monday, November 6th. Analysts expect Cogentix Medical to post earnings of ($0.01) per share for the quarter.

Cogentix Medical (NASDAQ:CGNT) last released its earnings results on Tuesday, August 1st. The medical device company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.02. Cogentix Medical had a negative return on equity of 13.83% and a negative net margin of 35.88%. The business had revenue of $14.06 million for the quarter, compared to analyst estimates of $13.90 million. On average, analysts expect Cogentix Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of Cogentix Medical, Inc. (CGNT) opened at 2.63 on Monday. Cogentix Medical, Inc. has a 12-month low of $1.52 and a 12-month high of $3.26. The company’s 50-day moving average price is $2.79 and its 200 day moving average price is $2.10. The company’s market cap is $160.20 million.

CGNT has been the topic of several recent research reports. Zacks Investment Research raised shares of Cogentix Medical from a “sell” rating to a “hold” rating in a research report on Tuesday, July 4th. JMP Securities initiated coverage on shares of Cogentix Medical in a research report on Friday, October 6th. They issued an “outperform” rating and a $5.00 price target on the stock.

TRADEMARK VIOLATION NOTICE: This report was first reported by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/10/30/cogentix-medical-inc-cgnt-to-release-earnings-on-monday.html.

A hedge fund recently raised its stake in Cogentix Medical stock. Northern Trust Corp boosted its holdings in Cogentix Medical, Inc. (NASDAQ:CGNT) by 0.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 73,926 shares of the medical device company’s stock after acquiring an additional 326 shares during the quarter. Northern Trust Corp owned 0.12% of Cogentix Medical worth $129,000 at the end of the most recent quarter. 12.64% of the stock is currently owned by hedge funds and other institutional investors.

About Cogentix Medical

Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).

Earnings History for Cogentix Medical (NASDAQ:CGNT)

Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.